ArticleOncotarget2015

Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma.

Alyssa L Kennedy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.